LEDIPASVIR/SOFOSBUVIR WITH RIBAVIRIN FOR 12 WEEKS IS EFFECTIVE AND SAFE IN TREATMENT-NAIVE GENOTYPE-3 HEPATITIS C-INFECTED PATIENTS IN CANADA Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Feld, J
  • Ramji, A
  • Shafran, S
  • Willems, B
  • Marotta, P
  • Huchet, E
  • Vachon, M-L
  • Svarovskaia, E
  • Huang, K
  • Hyland, R
  • Yun, C
  • Brainard, D
  • McHutchison, J
  • Tam, E
  • Bailey, R
  • Cooper, C
  • Yoshida, E
  • Greenbloom, S
  • Elkhashab, M
  • Borgia, Sergio
  • Swain, M

publication date

  • January 1, 2016